Summary: FDA announces draft guidance for industry on their policy to exercise enforcement discretion on delinquent notifications to encourage firms to submit NDIN to correct past failures. Read on to learn more.
0 Comments Click here to read/write comments
Tags: Product Testing & Certifications, Regulatory, Concept to Claim, ingredients, market access
